Company

Taligen Therapeutics

Taligen Therapeutics develops biotechnology solutions for research and therapy development.

About

Taligen Therapeutics developed biotechnology solutions for research and therapeutic development, serving academic institutions, pharmaceutical companies and research organizations. Founded in 2004, it was based in Cambridge, US. Alexion Pharmaceuticals, Inc. acquired the company in January 2011 for USD 111 mn.

4Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in